chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On her right arm about 3 inches down from the injection site was red; This spontaneous case was reported by a patient family member or friend and describes the occurrence of INJECTION SITE ERYTHEMA (On her right arm about 3 inches down from the injection site was red) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     The patient's past medical history included Stroke (She can't use her right arm.) in 2013.    On 02-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Nov-2021, the patient experienced INJECTION SITE ERYTHEMA (On her right arm about 3 inches down from the injection site was red). At the time of the report, INJECTION SITE ERYTHEMA (On her right arm about 3 inches down from the injection site was red) outcome was unknown.            No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter. Patient felt that the stroke could have had something to do with it (injection site red).
2-year-old patient might have received 0.25ml of the adult Moderna COVID-19 vaccine (Red Cap Vial).; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2-year-old patient might have received 0.25ml of the adult Moderna COVID-19 vaccine (Red Cap Vial).) in a 2-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2-year-old patient might have received 0.25ml of the adult Moderna COVID-19 vaccine (Red Cap Vial).). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2-year-old patient might have received 0.25ml of the adult Moderna COVID-19 vaccine (Red Cap Vial).) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided. Treatment information was not provided.   This case was linked to MOD-2022-607282, MOD-2022-607283 (Patient Link).
Pericarditis; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A contactable consumer reported herself that a female patient received the BNT162B2 (Pfizer Covid-19 vaccine), via an unspecified route of administration on an unspecified in 2021 (Batch/Lot Number: not provided) as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had been hospitalized twice due to fluid on heart and lung, chest pains and difficulty in breathing. These issues were ongoing. The patient had been diagnosed with pericarditis from cardiologist where the outer wall of heart was damaged because of the COVID vaccine. The patient stated that because of this shot, her life has changed and now she was susceptible to more breathing issues and chronic chest/heart pains. The patient did not recover.  The lot number for [BNT162B2], was not provided and will be requested during follow up.
About 1 week after the first 1/17/21 shot, I developed a circular redness with pimply raised bumps around injection site. For the first day or two, it was somewhat itchy. The red area grew to about three inches across, but persisted about 7 days before gradually decreasing.  Based on discussion with my GP, I had applied a steroid ointment and anti-bacterial ointment for the first few days.
After both doses of Pfizer Covid 19 vaccine patient reports significant elevated blood pressures that lasted 10-14 days.
c/o lt upper arm soreness since vax given on 5Nov90, no visible or palpable rxn noted, treatment was to apply heat & follow up /w family md if symptoms persist
Information has been received from a registered nurse concerning a female who in approximately December 2006, was vaccinated with Gardasil vaccine (yeast). In approximately December 2006, when administering the vaccine with the pre-filled syringe, the nurse released the spring before removing the syringe, therefore causing the patient pain at the injection site. No additional information was available at the time of reporting. No further information is available. 5/14/2010 Follow up: Additional information has been received rom the registered nurse via telephone. The nurse reported that the patient received the full dose of GARDASIL. No additional information is expected.
HEART PAIN; LEG PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced heart pain, and leg pain. The action taken with covid-19 vaccine  was not applicable. The outcome of the heart pain and leg pain was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Expired Pfizer COVD-19 vaccine was administered. Expired on 6/10/22 and administered on 6/15//22
Hives and itching were reported.  Benadryl and calamine were used to alleviate symptomes.
Patient called 4/15/2021, states had first dose 3/17/2021 and approximately 1 hour after injection developed chest pain, had extreme sweating, became short of breath and experienced nausea.  States went to bed and continued with these symptoms for 36 hours.  Took nitroglycerin to relieve chest pain.  Saw heart doctor today who told her to call us to report adverse reaction and advised to not take second dose.
1st day: chills, pale skin, vomiting, loose stool, body aches,, fatigue; 2nd day fatigue,  fever not exceeding 100.3, body aches. 3rd day: fatigue.  4th day felt 100% back to normal.
Difficulty breathing on and off everyday, rapid heartbeat at times, breathing stops during sleeping at times.
I left facility at 3:34 pm where I received the vaccine. At 6:30 pm I became so extremely tired I went to sleep in my clothes. I woke up a few hours later with a pounding headache; the sound of my heartbeat like a snare drum in my ears, nauseated and with a very, very sore arm. Later, throughout the night, I had continuous head pain, nightmares, chills and soreness. I am better today, but still shaky, I took one Naproxen tablet at around 1 am, as well as a melatonin.
Refrigeration excursions identified/undergone several temperature excursions; No adverse event; vaccines had undergone several temperature excursions and may have been administered to patient; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (vaccines had undergone several temperature excursions and may have been administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions) and NO ADVERSE EVENT (No adverse event) in a 57-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7146B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Sep-2022 at 11:56 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 23-Sep-2022 at 11:56 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (vaccines had undergone several temperature excursions and may have been administered to patient). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (vaccines had undergone several temperature excursions and may have been administered to patient), PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (vaccines had undergone several temperature excursions and may have been administered to patient) and PRODUCT TEMPERATURE EXCURSION ISSUE (Refrigeration excursions identified/undergone several temperature excursions).    No concomitant medication was provided.  The patient had ever been diagnosed with/ tested positive for COVID-19 was unknown.  On an unknown date, patient had received dose 1, dose 2, dose 3 of Moderna COVID-19  vaccines. Route was Intramuscular and body site was deltoid for all three doses. Patient had received on deltoid body site for dose 4.  The nurse reported that vaccines stored in the refrigerator that underwent several temperature excursions going back to August 2022.  It was reported that refrigeration excursions identified, state vaccine was housed in the units. There were excursions noted. Manufactures were notified and the state department and made aware of the situation.  It was reported that no adverse reactions were reported to their knowledge for any patients.  Treatment medication was not provided by the reporter
Elevated heart rate (120) beginning 30 min  after administration for several hours. A few episodes of irregular heart beat.  Was resolved sometime overnight.
The night of the shot, redness and itching developed around injection site. By the next morning, patient had fever, burning eyes, itchy throat and injection site was red, and painfully swollen. Went to ER and received 7 day steroid therapy.
Allergic reaction; Broke out in hives; Swelling to my right arm; Tingling sensation threw out my body; Cold sweats; Feel funny off n on; Bad headaches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic reaction), URTICARIA (Broke out in hives), PERIPHERAL SWELLING (Swelling to my right arm), PARAESTHESIA (Tingling sensation threw out my body) and COLD SWEAT (Cold sweats) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced HYPERSENSITIVITY (Allergic reaction), URTICARIA (Broke out in hives), PERIPHERAL SWELLING (Swelling to my right arm), PARAESTHESIA (Tingling sensation threw out my body), COLD SWEAT (Cold sweats), FEELING ABNORMAL (Feel funny off n on) and HEADACHE (Bad headaches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency and PREDNISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Allergic reaction), URTICARIA (Broke out in hives), PERIPHERAL SWELLING (Swelling to my right arm), PARAESTHESIA (Tingling sensation threw out my body), COLD SWEAT (Cold sweats), FEELING ABNORMAL (Feel funny off n on) and HEADACHE (Bad headaches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Follow-up received on 18-JUN-2021 and event details updated.
This spontaneous report as received from a nurse practitioner and refers to a multiple unspecified patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided. On an unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # M009378 with an expiration date 23-APR-2018, lot# L026602 with an expiration date 19-OCT-2017, and lot# M030380 with an expiration date 01-FEB-2019. There was no adverse effect reported. Administered doses of GARDASIL 9 experienced temperature excursion from 32 degrees Fahrenheit to 35 degrees Fahrenheit for 4 days. There was no previous temperature excursion. A digital data logger was not involved. This is on of several reports received from the same reports. Additional information has been requested. Sender's Comments: US-009507513-1706USA004377: US-009507513-1706USA004379: US-009507513-1706USA004376: US-009507513-1706USA004378.
Feeling sick; Headache; Injection site pain; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick), HEADACHE (Headache), INJECTION SITE PAIN (Injection site pain) and MYALGIA (Body aches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE and VENLAFAXINE for an unknown indication.    On 06-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced MALAISE (Feeling sick), HEADACHE (Headache), INJECTION SITE PAIN (Injection site pain) and MYALGIA (Body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (Feeling sick), HEADACHE (Headache), INJECTION SITE PAIN (Injection site pain) and MYALGIA (Body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
joint pain in my shoulders, hands, and wrist/Joint Pain From Shoulder to Hands on Both Arms (After the First Vaccine); The joints all have severe swelling; Both Hands swelled up/hands still swell up like grapefruits; Hands tingle under fingernails like its falling asleep; Not Able to Use Hands (After the First Vaccine); Muscle Pain From Shoulder to Hands on Both Arms (After the First Vaccine); This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (The joints all have severe swelling), PERIPHERAL SWELLING (Both Hands swelled up/hands still swell up like grapefruits), PARAESTHESIA (Hands tingle under fingernails like its falling asleep), MOBILITY DECREASED (Not Able to Use Hands (After the First Vaccine)) and MYALGIA (Muscle Pain From Shoulder to Hands on Both Arms (After the First Vaccine)) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Hypertension. Concomitant products included ALFUZOSIN for Benign prostatic hypertrophy, ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Jan-2021, the patient experienced JOINT SWELLING (The joints all have severe swelling), PERIPHERAL SWELLING (Both Hands swelled up/hands still swell up like grapefruits), PARAESTHESIA (Hands tingle under fingernails like its falling asleep), MOBILITY DECREASED (Not Able to Use Hands (After the First Vaccine)) and MYALGIA (Muscle Pain From Shoulder to Hands on Both Arms (After the First Vaccine)). The patient was treated with MELOXICAM at a dose of unknown; PREDNISONE at a dose of unknown and PARACETAMOL (TYLENOL) at a dose of unknown. At the time of the report, JOINT SWELLING (The joints all have severe swelling), PERIPHERAL SWELLING (Both Hands swelled up/hands still swell up like grapefruits), PARAESTHESIA (Hands tingle under fingernails like its falling asleep), MOBILITY DECREASED (Not Able to Use Hands (After the First Vaccine)) and MYALGIA (Muscle Pain From Shoulder to Hands on Both Arms (After the First Vaccine)) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Significant follow up-New events are added On 01-Jun-2021: Non-Significant F/U Case On 23-Jul-2021: Significant Follow-up received-Events and outcome of the events updated.
Patient started experiencing itching at night along with a "lump" and heat at the administration site. She came to me 2 days later with about a 4 inch by 9 inch area of redness on the patient's back side of her upper arm. The lump is where the administration was, not in the deltoid.
Delayed arm rash with swelling, itchiness, and redness appeared today. Also experiencing right underarm lymph node pain and swelling. Planning on using an ice pack and anti-itch cream to alleviate symptoms. No fever at this time.
Site sl swollen and red, 2 inches x2 inches, warm to touch but no fever, not worsening. Tylenol for pain given.
COULDN'T SLEEP AT NIGHT; WHOLE BODY FELT LIKE IT GOT HIT BY A CAR; FEELING SICK; MASSIVE FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the patient experienced couldn't sleep at night, whole body felt like it got hit by a car, feeling sick, and massive fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from couldn't sleep at night, whole body felt like it got hit by a car, feeling sick, and massive fever. This report was non-serious.
High fever 103, headache, chills, body aches, flu like symptoms, rash on arm, and soreness at injection sight and in my armpit.  The next day fever was down to about 101 and finally broke at 8:30 pm on 7/12/19 about 56 hours after injection. I haven't had a fever in 10 years for any reason and the fever really made me feel sick.
A report has been received from a Health Professional concerning a 10 year old, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 24-Jan-2014. The outcome of the event of EXPIRED FLUMIST is unknown. The report was considered to be non-serious.
Information has been received from a physician concerning a 17 year old female who was vaccinated on an unspecified date and her first dose of GARDASIL (lot# not reported). Subsequently the patient experienced hives all down her arm. She sought unspecified medical attention and her outcome was not reported. Additional information has been requested.
Parent states had large red area left mid-thigh after injections 2/20/03.  After red area went down and impression was left to left mid-thigh area.  Area noted 5/30/03 to measure 1cm x 2cm with some loss of pigment to area.  Mother had called doctor and was instructed was ok, just to watch.  Mother took child to clinic and was seen by clerical staff and told was ok.  Mother saw another doctorwith child and was referred to health department for documentation of area.  Mother unsure of time of visit and how soon reaction started with reddness of area.  We have pictures of area if needed.
Injection site is itchy since day 2 and is red and warm still,  12 days since injection A little less tender now, but still red and itchy and warm
Information has been received from a 39 year old male who in 1963 was vaccinated with measles virus vaccine live. The pt claims the vaccination was "inactive" and that he was "not sure if it was Attenuvax." Subsequently, the pt had a negative 0.84 titer. Unspecified medical attention was sought. Additional info has been requested.
Skin turned red, minor swelling, warm, itched. Cleared up in a week. Redness was about 5" x 4".
R09.02 HYPOXIA 10/20/2022 SUBSTANCE USE DISORDER COUNSELING R09.02 HYPOXIA 10/20/2022 AORTIC VALVE REGURGITATION R09.02 HYPOXIA 10/20/2022 AORTIC VALVE REGURGITATION R09.02 HYPOXIA 10/20/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA
pt recv vax 11AUG97 11AM & states 4PM began to cry, unable to comfort, noticed pt became sweaty pale, ? whether limp, lasted 20min-came to clinic @ 515PM;
pt inadvertently recv SC inj Tetanus Toxoid Absorbed, Purogenated. Pt devel inj site rxn of redness,swelling, pain & nodule. Pt declined to provide further info & permission for follow- up.
Patient states she was not feeling right; that her heart was racing; she also felt warm, and had dry mouth. We told her to sit down and rest while EMS arrives, gave her some water as well.
On 10/16/18 patient noticed her arm was sore when changing her clothes that night; site was sore to touch; no medication that night; on 10/17/18 patient took 50 mg BENADRYL po in the morning; site was warm to touch and swelling; that night patient took another 50 mg BENADRYL po and used BENADRYL topical cream to the site, patient also reports using ice for approximately 10-15 minutes that night; on 10/18/18 patient reports redness area; has enlarged, warm to the touch; patient reports using BENADRYL topical cream to site; patient now at health department to report adverse reaction. Right posterior arm with erythema at site of varicella injection; site measures 90mm X 50mm or erythema and 30mm X 18mm of induration. Patient reports that she feels that the site is getting larger. Patient denies having any anaphylactic reaction since receiving her vaccinations. FNP-C in office to look at site. Site is marked with surgical marker to monitor any changes in size. Patient to report to the Emergency Room if the site worsens or she has any breathing difficulties. Patient also given an appointment to return to the Health Department on Monday to assess reaction site.
pt recvd vax & approx 1 wk p/receiving the vax exp partial paralysis of lt arm; pt was described as having a brachial plexus type injury;
Multiple lesions to chin and neck area, Pos for vaccinia PCR. SPV contact transmission. CDC aware. Has scarring, and reports tingling/burning sensation in area.